ENTRY       D09190                      Drug
NAME        Anti-human thymocyte immunoglobulin, rabbit (JAN);
            Thymoglobuline (TN)
PRODUCT     THYMOGLOBULIN (Genzyme Corporation)
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      Therapeutic category: 6399
            ATC code: L04AA04
            Product: D09190<JP/US>
EFFICACY    Immunosuppressant
TARGET      CD2 [HSA:914] [KO:K06449]
            CD3 [HSA:915 916 917] [KO:K06450 K06451 K06452]
            CD4 [HSA:920] [KO:K06454]
            CD5 [HSA:921] [KO:K06455]
            CD7 [HSA:924] [KO:K06457]
            CD8 [HSA:925 926] [KO:K06458 K06459]
            IL2RA (CD25) [HSA:3559] [KO:K05068]
            ITGAL (CD11A) [HSA:3683] [KO:K05718]
  PATHWAY   hsa04640(3559+914+915+916+917+920+921+924+925+926)  Hematopoietic cell lineage
            hsa04658(3559+915+916+917+920)  Th1 and Th2 cell differentiation
            hsa04659(3559+915+916+917+920)  Th17 cell differentiation
            hsa04660(915+916+917+920+925+926)  T cell receptor signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA04 Antithymocyte immunoglobulin (rabbit)
                  D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunoglobulins
               Anti-thymocyte Globulin
                D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D09190  Anti-human thymocyte immunoglobulin, rabbit
            Drug classes [BR:br08332]
             Immunological agent
              DG02019  Interleukin inhibitor
               D09190  Anti-human thymocyte immunoglobulin, rabbit
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL2RA (CD25)
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CD2 family
                CD2
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
              Cell adhesion molecules: other families
               Integrins
                ITGAL (CD11A)
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
              Other cell surface molecules
               CD molecules
                CD3
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
                CD4
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
                CD5
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
                CD7
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
                CD8
                 D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09190
DBLINKS     PubChem: 96025870
///
